Patent classifications
A61K31/616
CHEMOTHERAPY FOR GLIOMA THROUGH NEURONAL CONVERSION
Compositions and methods for treating glioma and converting glioma cells into neurons are provided. The compositions contain an effective amount of SKL2001, and may also contain one, two, three or four of 0431542, LDN193189, CHIR99021, and DAPT. Pharmaceutical compositions containing SKL2001 and one, two, three or four of SB431542, LDN193189, CHIR99021, and DAPT are provided. Also provided are articles of manufacture which contain one or more sealed containers that contain SKL2001 and one, two, three or four of SB431542, LDN193189, CHIR99021, and DAPT, are provided. The articles of manufacture can contain printed material providing an indication that the compound(s) are for use in treating glioma.
Hair removal admixture with wax, antiseptic, analgesic, moisturizing oil, and chemical depilatory: Hair removal chemical composite/creamy wax.
Hair removal Chemical composite/creamy wax. This waxing mixture is used to easily remove unwanted hair. To those seeking quick removal of hair without much pain, discomfort, sores, and the like. Helps to calm the skin during the hair removal procedure. Good for those seeking to do waxing by themselves, and doesn't need professional supervision. Quick hair removal waxing chemical composition, a waxing admixture for the 21st century. Less pain, more hair removal.
Hair removal admixture with wax, antiseptic, analgesic, moisturizing oil, and chemical depilatory: Hair removal chemical composite/creamy wax.
Hair removal Chemical composite/creamy wax. This waxing mixture is used to easily remove unwanted hair. To those seeking quick removal of hair without much pain, discomfort, sores, and the like. Helps to calm the skin during the hair removal procedure. Good for those seeking to do waxing by themselves, and doesn't need professional supervision. Quick hair removal waxing chemical composition, a waxing admixture for the 21st century. Less pain, more hair removal.
DELIVERY SYSTEMS FOR RELEASE OF ACTIVE COMPOUNDS
Drug delivery systems and wearable articles including the drug delivery systems are provided. The drug delivery systems may include a substrate coated with at least one polymer and at least one active compound. The substrate is operable to include yarns, yarn precursors, threads, filaments, fibers, and/or other suitable substrates. Methods for manufacturing drug delivery systems are also provided. The methods are operable to include disposing a solution including a monomer and an active compound on the substrate. The methods are also operable to include exposing the solution and the substrate to UV light to initiate polymerization of the solution.
DELIVERY SYSTEMS FOR RELEASE OF ACTIVE COMPOUNDS
Drug delivery systems and wearable articles including the drug delivery systems are provided. The drug delivery systems may include a substrate coated with at least one polymer and at least one active compound. The substrate is operable to include yarns, yarn precursors, threads, filaments, fibers, and/or other suitable substrates. Methods for manufacturing drug delivery systems are also provided. The methods are operable to include disposing a solution including a monomer and an active compound on the substrate. The methods are also operable to include exposing the solution and the substrate to UV light to initiate polymerization of the solution.
ADRENOMEDULLIN-ANALOGUES FOR LONG-TERM STABILIZATION AND THEIR USE
The invention relates to stabilized Adrenomedullin derivatives and use thereof. In particular, the invention relates to novel, biologically active, stabilized Adrenomedullin (ADM) compounds. The invention further relates to the compounds for use in a method for the treatment and/or prevention of diseases, especially of cardiovascular, edematous and/or inflammatory disorders, and to medicaments comprising the compounds for treatment and/or prevention of cardiovascular, edematous and/or inflammatory disorders.
ADRENOMEDULLIN-ANALOGUES FOR LONG-TERM STABILIZATION AND THEIR USE
The invention relates to stabilized Adrenomedullin derivatives and use thereof. In particular, the invention relates to novel, biologically active, stabilized Adrenomedullin (ADM) compounds. The invention further relates to the compounds for use in a method for the treatment and/or prevention of diseases, especially of cardiovascular, edematous and/or inflammatory disorders, and to medicaments comprising the compounds for treatment and/or prevention of cardiovascular, edematous and/or inflammatory disorders.
Method for virus assay
The present invention relates to a method for virus assay. More closely the invention relates a method for total quantification of adenovirus in a sample as well as total and functional (active) adenovirus in a sample. The method for determining adenovirus concentration in a sample comprises subjecting said sample to SPR (surface plasmon resonance) assay with immobilized FX (Factor X) and/or immobilized CAR (coxsackievirus and adenovirus receptor) on a sensor surface, wherein the adenovirus concentration is determined from sample binding to immobilized FX and/or immobilized CAR. CAR can be replaced by an ligand binding to adenovirus fiber, such as an anti-adenovirus fiber antibody. FX can be replaced by a ligand binding to adenovirus hexon, such as an anti-adenovirus hexon antibody. The method can be used for quality control in an adenovirus purification process, for example for gene therapy.
Substrates for vaporizing and delivering an aerosol
Substrates for use with an aerosol delivery device to vaporize and deliver an aerosol to a user include a base material, an aerosol former and an aerosol agent. In a method for forming the substrates, a mixture of substrate materials is extruded and then spheronized to produce pellet substrates that are generally spherical, substantially spherical or rounded, or in the form of relatively short rods having rounded ends. In another method for forming the substrates, a base material is coated with a first coating and optionally the base material having the first coating thereon is subsequently coated with a second coating so as to produce pellet substrates having a relatively smooth, dry exterior surface. In this manner, the substrates are formable relative to one another and can be easily and readily loaded into and removed from the aerosol delivery device.
Substrates for vaporizing and delivering an aerosol
Substrates for use with an aerosol delivery device to vaporize and deliver an aerosol to a user include a base material, an aerosol former and an aerosol agent. In a method for forming the substrates, a mixture of substrate materials is extruded and then spheronized to produce pellet substrates that are generally spherical, substantially spherical or rounded, or in the form of relatively short rods having rounded ends. In another method for forming the substrates, a base material is coated with a first coating and optionally the base material having the first coating thereon is subsequently coated with a second coating so as to produce pellet substrates having a relatively smooth, dry exterior surface. In this manner, the substrates are formable relative to one another and can be easily and readily loaded into and removed from the aerosol delivery device.